Literature DB >> 12083807

Expression of the liver form of arginase in erythrocytes.

Phillip S Kim1, Ramaswamy K Iyer, Kan V Lu, Hong Yu, Ardeshir Karimi, Rita M Kern, Denice K Tai, Stephen D Cederbaum, Wayne W Grody.   

Abstract

Arginase I (AI) has a critical function in mammalian liver as the final enzyme in the urea cycle responsible for the disposal of ammonia from protein catabolism. AI is also expressed in various extrahepatic tissues and may play a role in regulating arginine levels and in providing ornithine for biosynthetic reactions that generate various critical intermediary metabolites such as glutamate, glutamine, GABA, agmatine, polyamines, creatine, proline, and nitric oxide. AI is expressed in red blood cells (RBCs) only in humans and certain higher primates. Macaca fascicularis has been identified as an evolutionary transition species in which RBC-AI expression is co-dominantly regulated. The M. fascicularis AI gene was analyzed to understand AI expression in erythrocytes. Erythroid progenitor cells [nucleated red blood cells (nRBCs)] isolated from cord blood were utilized to demonstrate AI expression by immunocytochemical staining using anti-AI antibody. Introduction of EGFP reporter vectors into nRBC showed that the proximal 1.2 kbp upstream of the AI gene is sufficient for AI expression. Expression of a second arginase isoform, AII, in nRBCs was discovered by cDNA profiling. This contrasts with mature fetal or adult RBCs which contain only the AI protein. In addition, an alternatively spliced AI (AI(')) variant was observed from erythroid mRNA analysis with an alternative splice acceptor site located within intron 2, causing the insertion of eight additional amino acids yet retaining significant enzymatic activity. (c) 2002 Elsevier Science (USA).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12083807     DOI: 10.1016/s1096-7192(02)00034-3

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  15 in total

1.  Hemolysis-associated pulmonary hypertension in thalassemia.

Authors:  Claudia R Morris; Frans A Kuypers; Gregory J Kato; Lisa Lavrisha; Sandra Larkin; Titi Singer; Elliott P Vichinsky
Journal:  Ann N Y Acad Sci       Date:  2005       Impact factor: 5.691

2.  2-aminoimidazole amino acids as inhibitors of the binuclear manganese metalloenzyme human arginase I.

Authors:  Monica Ilies; Luigi Di Costanzo; Michelle L North; Jeremy A Scott; David W Christianson
Journal:  J Med Chem       Date:  2010-05-27       Impact factor: 7.446

3.  Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease.

Authors:  Claudia R Morris; Gregory J Kato; Mirjana Poljakovic; Xunde Wang; William C Blackwelder; Vandana Sachdev; Stanley L Hazen; Elliott P Vichinsky; Sidney M Morris; Mark T Gladwin
Journal:  JAMA       Date:  2005-07-06       Impact factor: 56.272

4.  Recent Advances in Understanding of Alzheimer's Disease Progression through Mass Spectrometry-Based Metabolomics.

Authors:  Jericha Mill; Lingjun Li
Journal:  Phenomics       Date:  2022-02-22

5.  A colorimetric microplate assay method for high-throughput analysis of arginase activity in vitro.

Authors:  Efewmonkiekie W Iyamu; Toshio Asakura; Gerald M Woods
Journal:  Anal Biochem       Date:  2008-08-23       Impact factor: 3.365

Review 6.  Arginase: an emerging key player in the mammalian immune system.

Authors:  Markus Munder
Journal:  Br J Pharmacol       Date:  2009-09-17       Impact factor: 8.739

7.  L-arginine and asymmetric dimethylarginine are early predictors for survival in septic patients with acute liver failure.

Authors:  Thorsten Brenner; Thomas H Fleming; Claudia Rosenhagen; Ute Krauser; Markus Mieth; Thomas Bruckner; Eike Martin; Peter P Nawroth; Markus A Weigand; Angelika Bierhaus; Stefan Hofer
Journal:  Mediators Inflamm       Date:  2012-05-06       Impact factor: 4.711

8.  Nitric oxide synthetic pathway in patients with microvascular angina and its relations with oxidative stress.

Authors:  Benedetta Porro; Sonia Eligini; Fabrizio Veglia; Alessandro Lualdi; Isabella Squellerio; Susanna Fiorelli; Marta Giovannardi; Elisa Chiorino; Alessia Dalla Cia; Mauro Crisci; José Pablo Werba; Elena Tremoli; Viviana Cavalca
Journal:  Oxid Med Cell Longev       Date:  2014-04-22       Impact factor: 6.543

Review 9.  Nitric oxide and arginine dysregulation: a novel pathway to pulmonary hypertension in hemolytic disorders.

Authors:  Claudia R Morris; Mark T Gladwin; Gregory J Kato
Journal:  Curr Mol Med       Date:  2008-11       Impact factor: 2.222

10.  The human neonatal small intestine has the potential for arginine synthesis; developmental changes in the expression of arginine-synthesizing and -catabolizing enzymes.

Authors:  Eleonore S Köhler; Selvakumari Sankaranarayanan; Christa J van Ginneken; Paul van Dijk; Jacqueline L M Vermeulen; Jan M Ruijter; Wouter H Lamers; Elisabeth Bruder
Journal:  BMC Dev Biol       Date:  2008-11-10       Impact factor: 1.978

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.